"Company†) (Nasdaq: ENGN), a clinical-stage, non-viral genetic medicines company, today announced that BioSpace has named the company to its 2026 Best Places to Work. enGene is among 50 U.S. operating employers recognized as one of the most desirable workplaces in the life sciences industry. "Recognition as a BioSpace Best Place to Work honors enGene's commitment to create a positive work environment, underpinned by our m. BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. ("enGene†or the ...